Value of immunophenotype in intensively treated adult acute lymphoblastic leukemia: Cancer and leukemia group B study 8364

Blood

Volumn 93, Issue 11, 1999, Pages 3931-3939

  Czuczman, Myron S ^a   Dodge, Richard K ^b   Stewart, Carleton C ^b   Frankel, Stanley R ^b   Davey, Frederick R ^b   Powell, Bayard L ^b   Szatrowski, Ted P ^b   Schiffer, Charles A ^b   Larson, Richard A ^b   Bloomfield, Clara D ^b  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ASPARAGINASE; CD19 ANTIGEN; CD34 ANTIGEN; COMMON ACUTE LYMPHOBLASTIC LEUKEMIA ANTIGEN; CYCLOPHOSPHAMIDE; DAUNORUBICIN; HEMOGLOBIN; LYMPHOCYTE ANTIGEN; PREDNISONE; VINCRISTINE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ADULT; AGE; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CHEMOSENSITIVITY; CHROMOSOME TRANSLOCATION 11; CHROMOSOME TRANSLOCATION 4; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; PHILADELPHIA 1 CHROMOSOME; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; SEX DIFFERENCE; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; B-LYMPHOCYTES; CELL LINEAGE; FEMALE; HUMANS; IMMUNOPHENOTYPING; LEUKEMIA, LYMPHOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; T-LYMPHOCYTES; TUMOR MARKERS, BIOLOGICAL;

EID: 0033153010     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Champlin R, Gale RP: Acute lymphoblastic leukemia: recent advances in biology and therapy. Blood 73:2051, 1989
2. Cortes JE, Kantarjian HM: Acute lymphoblastic leukemia: A comprehensive review with emphasis on biology and therapy. Cancer 76:2393, 1995
3. Hoelzer DF: Diagnosis and treatment of adult acute lymphocytic leukemia, in Wiernik PH, Canellos GP, Dutcher JP, Kyle RA (eds): Neoplastic Diseases of the Blood (ed 3). New York, NY, Churchill Livingston, 1996, p 295
4. Pui C-H, Behm FG, Crist WM: Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 82:343, 1993
5. Loken MR, Shah VO, Dattilio KL, Civin CI: Flow cytometric analysis of human bone marrow. II. Normal B lymphocyte development. Blood 70:1316, 1987
6. Uckun FM, Muraguchi A, Ledbetter JA, Kishimoto T, O'Brien RT, Roloff JS, Gajl-Peczalska K, Provisor A, Koller B: Biphenotypic leukemic precursors in CD2+CD19+ acute lymphoblastic leukemia and their putative normal counterparts in human fetal hematopoietic tissues. Blood 73:1000, 1989
7. Sobol RE, Royston I, LeBien TW, Minowada J, Anderson K, Davey FR, Cuttner J, Schiffer C, Ellison RR, Bloomfield CD: Adult lymphoblastic leukemia phenotypes defined by monoclonal antibodies. Blood 65:730, 1985
8. Sobol RE, Mick R, Royston I, Davey FR, Ellison RR, Newman R, Cuttner J, Griffin JD, Collins H, Nelson DA, Bloomfield CD: Clinical importance of myeloid antigen expression in adult acute lymphoblastic leukemia. N Engl J Med 316:1111, 1987
9. Sobol RE, Bloomfield CD, Royston I: Immunophenotyping in the diagnosis and classification of acute lymphoblastic leukemia. Clin Lab Med 8:151, 1988
10. Larson RA, Dodge RK, Burns P, Lee EJ, Stone RM, Schulman P, Duggan D, Davey FR, Sobol RE, Frankel SR, Hooberman AL, Westbrook CA, Arthur DC, George SL, Bloomfield CD, Schiffer CA: A five-drug remission induction regimen with intensive consolidation for adults with acute lymphoblastic leukemia: Cancer and Leukemia Group B Study 8811. Blood 85:2025, 1995
11. Larson RA, Dodge RK, Linker CA, Stone RM, Powell BL, Lee EJ, Schulman P, Davey FR, Frankel SR, Bloomfield CD, George SL, Schiffer CA: A randomized controlled trial of filgrastim during remission induction and consolidation chemotherapy for adults with acute lymphoblastic leukemia: CALGB 9111. Blood 92:1556, 1998
12. Szatrowski TP, Larson RA, Dodge R, Sklar J, Reynolds C, Westbrook CA, Hurd D, Kolitz J, Velez-Garcia E, Frankel SR, Stewart C, Bloomfield CD, Schiffer CA: The effect of anti-B4-blocked ricin (anti-B4-bR) on minimal residual disease (MRD) in adults with B-lineage acute lymphoblastic leukemia (ALL) (CALGB 9311, 8762, 8763), Blood 88:669a, 1996 (abstr, suppl 1)
13. Frankel SR, Kurtzberg J, DeOleivera D, Dodge R, Peterson B, Powell BL, Larson RA, Schiffer CA: Toxicity and pharmacokinetics of peg-asparaginase (peg-asp) in newly diagnosed adult acute lymphoblastic leukemia (ALL): CALGB 9511. Blood 88:669a, 1996 (abstr, suppl 1)
14. Willman CL, Stewart CC: General principles of multiparameter flow cytometric analysis: Applications of flow cytometry in the diagnostic pathology laboratory. Semin Diag Pathol 6:3, 1989
15. Stewart CC: Multiparameter analysis of leukocytes by flow cytometry, in Darzynkiewicz Z, Crissman H (eds): Methods of Cell Biology, vol 33. New York, NY, Academic, 1990, p 427
16. Bloomfield CD, Wurster-Hill D, Peng G, Le Beau M, Tantravahi R, Testa J, Davey FR, Ellison RR, Cuttner J, Schiffer C, Sobol RE, Lunghofer B, Carey M, Mick R, Arthur D: Prognostic significance of the Philadelphia chromosome in adult acute lymphoblastic leukemia, in Gale RP, Hoelzer D (eds): Acute Lymphoblastic Leukemia, UCLA Symposia on Molecular and Cellular Biology. New York, NY, Wiley-Liss, 1990
17. Westbrook CA, Dodge R, Szatrowski TP, Horrigan SK, Kim SJ, Wu D, Jantzen N, Schiffer CA, Bloomfield CD: PCR monitoring of minimal residual disease identifies good outcome in BCR/ABL positive acute lymphoblastic leukemia (ALL): CALGB 8762. Blood 88:638a, 1996 (abstr, suppl 1)
18. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457, 1958
19. Simon R, Lee YJ: Nonparametric confidence limits for survival probabilities and median survival time. Cancer Treat Rep 66:37, 1982
20. Mantel N: Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50:163, 1966
21. Koziol JA, Reid N: On multiple comparisons among k samples subject to unequal patterns of censorship. Commun Statist Theor Meth A6:1149, 1977
22. Hoelzer D, Thiel E, Loffler H, Buchner T, Ganser A, Heil G, Koch P, Freund M, Diedrich H, Ruhl H, Maschmeyer G, Lipp T, Nowrousian MR, Burkert M, Gerecke D, Pralle H, Muller U, Lunscken CH, Fulle H, Ho AD, Kuchler R, Busch FW, Schneider W, Gorg CH, Emmerich B, Braumann D, Vaupel HA, von Paleske A, Bartels H, Neiss A, Messerer D: Prognostic factors in a multicenter study for treatment of acute lymphoblastic leukemia in adults. Blood 71:123, 1988
23. Thomas X, Archimbaud E, Charrin C, Magaud JP, Fiere D: CD34 expression is associated with major adverse prognostic factors in adult acute lymphoblastic leukemia. Leukemia 9:249, 1995
24. Pui CH, Hancock ML, Head DR, Rivera GK, Look AT, Sandlund JT, Behm FG: Clinical significance of CD34 expression in childhood acute lymphoblastic leukemia. Blood 82:889, 1993
25. Pui CH, Rivera GK, Hancock ML, Raimondi SC, Sandlund JT, Mahmoud HH, Ribeiro RC, Furman WL, Hurwitz CA, Crist WM, Behm FG: Clinical significance of CD10 expression in childhood acute lymphoblastic leukemia. Leukemia 7:35, 1993
26. Ludwig W-D, Rieder H, Bartram CR, Heinze B, Schwartz S, Gassmann W, Löeffler H, Hossfeld D, Heil G, Handt S, Heyll A, Diedrich H, Fischer K, Weiss A, Völkers B, Ülker A, Fonatsch C, Gökbuget N, Thiel E, Hoelzer D: Immuno-phenotype and genotypic features, clinical characteristics, and treatment of outcome of adult pro-B acute lymphoblastic leukemia: Results of the German multicenter trials GMALL 03/87 and 04/89. Blood 92:1898, 1998
27. Smith M, Arthur D, Camitta B, Carroll AJ, Crist W, Gannon P, Gelber R, Heerema N, Korn EL, Link M, Murphy S, Pui CH, Pullen J, Reaman G, Sallan SE, Sather H, Shuster J, Simon R, Trigg M, Tubergen D, Uckun F, Ungerleider R: Uniform approach and risk classification and treatment assignment for children with acute lymphoblastic leukemia. J Clin Oncol 14:18, 1996
28. Drexler HG, Thiel E, Ludwig WD: Review of the incidence and clinical relevance of myeloid antigen-positive acute lymphoblastic leukemia. Leukemia 5:637, 1991
29. Boldt DH, Kopecky KJ, Head D, Gehly G, Radich JP, Appelbaum FR: Expression of myeloid antigens by blast cells in acute lymphoblastic leukemia of adults. The Southwest Oncology Group Experience. Leukemia 8:2118, 1994
30. Urbano-Ispizua A, Matutes E, Villamor N, Ribera JM, Feliu E, Montserrat E, Granena A, Vives-Corrons JL, Rozman C: Clinical significance of the presence of myeloid associated antigens in acute lymphoblastic leukemia. Br J Haematol 75:202, 1990
31. Lee EJ, Petroni GR, Freter CE, Johnson JL, Schiffer CA, Peterson BA: Brief duration high intensity chemotherapy for patients with small non-cleaved lymphoma (IWF J) and FAB L3 acute lymphocytic leukemia in adults: Preliminary results of CALGB 9251. Proc Am Soc Clin Oncol 16:24a, 1997 (abstr)
32. Pui CH, Evans WE: Acute lymphoblastic leukemia. N Engl J Med 339:605, 1998